Free Trial
OTCMKTS:NMRD

Nemaura Medical Earnings Date & Estimates

Nemaura Medical logo
$0.0001 0.00 (0.00%)
As of 11/9/2026 02:59 PM Eastern

Nemaura Medical is estimated to report earnings on Tuesday, November 17, 2026.

What Analysts Expect from Nemaura Medical

Nemaura Medical is expected to post earnings of -$0.08 per share on revenue of $200 thousand. Nemaura Medical has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.08
Expected Revenue
$200 thousand

Recent Track Record

Last Reported
Q3 2024
Last Quarter EPS
-$0.12
EPS Beat Rate
2 of last 8 quarters

Nemaura Medical Earnings FAQ

Nemaura Medical (OTCMKTS:NMRD) is estimated to report earnings on Tuesday, November 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Nemaura Medical to post earnings of -$0.08 per share for the quarter.

The consensus revenue estimate for Nemaura Medical is $200 thousand for the quarter.

Nemaura Medical Earnings Headlines

NMRD Nemaura Medical Inc.
My prediction for December 8th
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
Nemaura Medical Inc (NMRD)
NXNN Nexeon Medsystems Inc
See More Nemaura Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nemaura Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nemaura Medical and other key companies, straight to your email.

About Nemaura Medical

Nemaura Medical (OTCMKTS:NMRD), Inc. is a medical technology company focused on developing wearable solutions for diabetes and metabolic health monitoring. Its principal product is SugarBEAT, a non-invasive glucose monitoring system designed to provide continuous or periodic glucose readings without the need for traditional finger-stick testing.

SugarBEAT is designed to use a disposable skin patch, a reusable sensor transmitter and a software application to collect and display glucose information. The company has also described applications for the technology in diabetes management, prediabetes monitoring and broader wellness programs.

Nemaura Medical has pursued regulatory clearances and commercial opportunities in international markets, including the United Kingdom and Europe. The company is headquartered in Fremont, California. Public information about its current commercial operations, product availability and leadership may be limited, and the regulatory status of its products can vary by geography.

View Nemaura Medical Profile